Red River Research Partners

Fargo, North Dakota 58103

3 studies enrolling now · 8 studies all time

What they study most

Atopic Dermatitis (AD), Chronic Inducible Urticaria, Hidradenitis Suppurativa, Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Obesity, Presbyopia, Prurigo Nodularis, Psoriasis, Psoriasis (PsO)

Studies at this site

• Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo — Recruiting now
• Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis — Recruiting now
• Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense — Running, not enrolling
• Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight — Completed
• A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria — Completed
• Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia — Completed
• A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream — Completed